Rate of tuberculosis screening and isoniazid prophylaxis treatment among human immunodeficiency virus patients in Obio/Akpor Local Government Area: A retrospective study
Rattachement africain : Nigéria, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Background The co-occurrence of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) has been recognised as a global public health problem with considerable mutual interaction and a leading cause of death worldwide. Aim To determine the rate of TB screening among People Living with HIV (PLWH) and treatment with isoniazid (INH) prophylaxis in directly observed treatment short course (DOTS) clinics in Primary Healthcare centres (PHCs) in Obio/Akpor Local Government Area of Rivers state. Materials and Method This clinic-based, two-year retrospective cross-sectional study involved a complete review and abstraction of all records for HIV patients (18 years and above) who have been receiving HIV care and treatment for at least 6 months prior to the study in DOTS clinics in five selected PHCs in OBALGA. The data were extracted using a checklist while the statistical analysis of the study was carried out using SPSS version 23. Results The proportion of HIV-positive patients screened for TB was 79.8% while those who had TB diagnostic evaluation among them was 38.6%, and 38.7% of the HIV/TB co-infected patients were placed on INH prophylaxis. Conclusion Insufficient attention is being paid to TB diagnostic evaluation and IPT. Hence, it is recommended that the PHCs in the LGA should be equipped with appropriate devices for TB diagnosis as well as engage the Healthcare Workers in sensitization workshops on the need for continuous screening of PLWH for TB.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Rate of tuberculosis screening and isoniazid prophylaxis treatment among human immunodeficiency virus patients in Obio/Akpor Local Government Area: A retrospective study
- Date Crossref
- 26/01/2023
- Éditeur
- openRxiv
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Port Harcourt Department of Human Physiology University of Port Harcourt, Nigéria (code pays fourni par la source)Université ou école supérieure
-
Bowling Green State University Department of Biological Sciences pays non établi dans la noticeUniversité ou école supérieure
-
School of Public Health University of Port Harcourt, Nigéria (ville ou établissement reconnu, pays non nommé)Université ou école supérieure
Department of Human Physiology — University of Port Harcourt (University of Port Harcourt, Nigéria), Department of Biological Sciences — Bowling Green State University et School of Public Health (University of Port Harcourt, Nigéria). Pays d’affiliation : Nigéria.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.